Julie Gerberding

Julie Louise Gerberding is President, Chief Executive Officer & Director at Foundation for the National Institutes of Health, Inc. since 2022.
Holds director positions at Biotechnology Innovation Organization, Accordia Global Health Foundation since 2009, MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. since 2010, SummerBio LLC since 2022, and Independent Director at McKesson Corp.
starting 2025.
Serves as Trustee at Case Western Reserve University and Mayo Clinic since 2022.
Member of the National Academy of Public Administration and the National Academy of Medicine (United States).
Formerly Independent Director at Cerner Corp.
from 2017 to 2022.
Director at Centers for Disease Control & Prevention from 2002 to 2009.
Co-Chairman at MSD Vaccines Ltd. President of Merck Vaccine Division from 2010 to 2014.
Executive Vice President-Strategic Communications at Merck & Co., Inc. from 2015 to 2016.
Independent Director at HilleVax, Inc. from 2021 to 2025.
Director at Project HOPE-The-People-To-People Health Foundation, Inc. and Independent Director at AfterNext HealthTech Acquisition Corp.
Education includes undergraduate and doctorate degrees from Case Western Reserve University and a graduate degree from the University of California, Berkeley conferred in 1990.